The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids.
Journal Information
Full Title: Mediators Inflamm
Abbreviation: Mediators Inflamm
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflicts of Interest No conflict of interest is involved in this study."
Funding Disclosure
Evidence found in paper:
"This paper was supported by the National Natural Science Foundation of China (Grant No. 82102372), Natural Science Foundation of Shandong Province (Grant No. ZR2020MC060), Jinan Science and Technology Plan (no. 202019200), and Shandong Provincial Medical and Health Science and Technology Development Plan (Grant No. 2018WS276)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025